Developing Human iPSC-based Cell and Organoids for Disease Modelling

Background

Human induced pluripotent cell-derived organoid models are developed to mimic various diseases like neurodegenerative disorders. Progress in stem cell and regenerative medicine field has been aided by generating iPSC-derived organoid models. These are necessary for disease modeling, drug discovery studies, developing personalized therapeutics and precision medicine. Tools like genome editing are being used to develop iPSC-derived platforms for research and clinical testing.  

Learning Outcome (LO)

  • LO #1: Developing iPSC-derived platforms for organ and disease modeling, a review of available literature on specific models.  
  • LO #2: Applications of iPSC-based models in Clinical settings will be discussed. Ethical challenges in using these models in clinical settings and outlook will be proposed. 

What is on offer?

×